Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Invion Ltd
IVXCurrent price
0.002 AUD
0 AUD (0.00%)
Last closed
0.002 AUD
Company
www.inviongroup.com
ISIN
AU000000IVX4
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Australian Securities Exchange
Capitalization
13 099 995 AUD
Yield for 12 month
-60.00 %
1Y
3Y
5Y
10Y
15Y
IVX
Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of various cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, anogenital, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to develop a novel photosensitiser for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia. Address: 100 Albert Road, Melbourne, VIC, Australia, 3205
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.16 AUDP/E ratio
–Dividend Yield
–Current Year
+3 645 351 AUD
Last Year
+4 050 373 AUD
Current Quarter
+1 446 416 AUD
Last Quarter
+2 198 934 AUD
Current Year
+3 645 351 AUD
Last Year
+1 190 532 AUD
Current Quarter
+1 446 416 AUD
Last Quarter
+638 712 AUD
Key Figures IVX
1 year
3 years
5 years
10 years
EBITDA
-4 796 836 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.57 %
PEG Ratio
–
Return On Equity TTM
-34.28 %
Wall Street Target Price
0.16 AUD
Revenue TTM
3 645 351 AUD
Book Value
0.002 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-32.1 %
Dividend Yield
–
Gross Profit TTM
1 190 531 AUD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-152.34 %
Dividend Analytics IVX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IVX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
875:691
Payout Ratio
–
Last Split Date
14.02.2018
Dividend Date
–
Stock Valuation IVX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.3815
Price Sales TTM
3.5936
Enterprise Value EBITDA
-25.5842
Price Book MRQ
0.9195
Financials IVX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IVX
For 52 weeks
0.002 AUD
0.0079 AUD
50 Day MA
0.0035 AUD
Shares Short Prior Month
–
200 Day MA
0.0046 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart